PUBLISHER: GlobalData | PRODUCT CODE: 1410851
PUBLISHER: GlobalData | PRODUCT CODE: 1410851
Implantable Loop Recorders Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033 is built to visualize quantitative market trends within Cardiovascular Devices therapeutic area.
The model discusses in detail the impact of COVID-19 on Implantable Loop Recorders market for the year 2020 and beyond. Syncope is a sudden loss of consciousness caused by systemic arterial hypotension resulting from reflex vasodilatation or bradycardia or both. Unexplained Syncope refers to the type of syncope where no clear cardiologic or neurological diagnosis can be found.
Implantable loop recorders (ILRs) can be useful in helping differentiate between different causes of transient loss of consciousness. The ILR has a safe and effective way of monitoring patients suffering from recurrent unexplained syncope. An ILR is a subcutaneous, single-lead, electrocardiographic (ECG) monitoring device used for diagnosis in patients with recurrent unexplained episodes of palpitations or syncope, along with long-term monitoring in patients at risk for or with atrial fibrillation, structural heart disease, bundle branch block, recurrent neurally mediated syncope etc.
Each of the covered 39 country's color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. To increase the data transparency, the interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.
Key Inclusions of the market model are -
Currently marketed Implantable Loop Recorders and evolving competitive landscape -
Global, Regional and Country level market specific insights -
Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.
Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.
Companies covered: Medtronic Plc, Abbott Laboratories, Biotronik SE & Co KG, Boston Scientific Corp.
Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.
This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -
The model will enable you to -
Not Applicable
Not Applicable
Not Applicable